Get started
HEPION PHARMACEUTICALS INCHEPION PHARMACEUTICALS INCHEPION PHARMACEUTICALS INC

HEPION PHARMACEUTICALS INC

No trades
See on Supercharts
Overview
Financials News Ideas Technicals

336 chart

Upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats

Market capitalization
‪5.78 M‬EUR
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−11.17EUR
Net income (FY)
‪−44.33 M‬EUR
Revenue (FY)
—
Shares float
‪5.39 M‬
Beta (1Y)
0.09

About Hepion Pharmaceuticals, Inc.

Sector
Health Technology
CEO
John T. Cavan
Headquarters
Edison
Website
hepionpharma.com
Employees (FY)
22
Founded
2013
Hepion Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development of drug therapy for treatment of chronic liver diseases. It focuses on the development of its product candidate rencofilstat, a cyclophilin inhibitor that targets biochemical pathways involved in the progression of liver disease. The company was founded on May 15, 2013 and is headquartered in Edison, NJ.

Financials

Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

Ideas

See all ideas 

News

Keep reading

Technicals

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Stock brokers

Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of 336 is 1.00 EUR — it has increased by 2.56% in the past 24 hours. Watch HEPION PHARMACEUTICALS INC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on GETTEX exchange HEPION PHARMACEUTICALS INC stocks are traded under the ticker 336.
336 stock has fallen by 26.47% compared to the previous week, the month change is a 55.36% fall, over the last year HEPION PHARMACEUTICALS INC has showed a 83.33% decrease.
336 reached its all-time high on May 23, 2023 with the price of 17.88 EUR, and its all-time low was 0.27 EUR and was reached on Dec 29, 2022. View more price dynamics on 336 chart.
See other stocks reaching their highest and lowest prices.
336 stock is 2.50% volatile and has beta coefficient of 0.09. Track HEPION PHARMACEUTICALS INC stock price on the chart and check out the list of the most volatile stocks — is HEPION PHARMACEUTICALS INC there?
Today HEPION PHARMACEUTICALS INC has the market capitalization of ‪5.78 M‬, it has increased by 6.17% over the last week.
Yes, you can track HEPION PHARMACEUTICALS INC financials in yearly and quarterly reports right on TradingView.
HEPION PHARMACEUTICALS INC is going to release the next earnings report on May 16, 2024. Keep track of upcoming events with our Earnings Calendar.
336 net income for the last quarter is ‪−10.02 M‬ EUR, while the quarter before that showed ‪−9.96 M‬ EUR of net income which accounts for −0.62% change. Track more HEPION PHARMACEUTICALS INC financial stats to get the full picture.
No, 336 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of May 16, 2024, the company has 22.00 employees. See our rating of the largest employees — is HEPION PHARMACEUTICALS INC on this list?
Like other stocks, 336 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade HEPION PHARMACEUTICALS INC stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So HEPION PHARMACEUTICALS INC technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating HEPION PHARMACEUTICALS INC stock shows the sell signal. See more of HEPION PHARMACEUTICALS INC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.